Results 1 to 10 of about 18,287 (255)

Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting [PDF]

Research and Practice in Thrombosis and Haemostasis, 2022
Background Desmopressin is an important treatment option in nonsevere hemophilia A because it has several benefits compared with factor (F) concentrates, including no inhibitor risk and much lower costs.
Anne‐Fleur Zwagemaker, Fabienne R. Kloosterman, Michiel Coppens, Samantha C. Gouw, Sara Boyce, Catherine N. Bagot, Erik A. M. Beckers, Paul Brons, Giancarlo Castaman, Jeroen Eikenboom, Shannon Jackson, Marieke J. H. A. Kruip, Frank W. G. Leebeek, Karina Meijer, Laurens Nieuwenhuizen, Ingrid Pabinger, Karin Fijnvandraat, the DYNAMO Study Group   +17 more
doaj   +4 more sources

Desmopressin in moderate hemophilia A patients: a treatment worth considering [PDF]

Haematologica, 2018
Desmopressin increases endogenous factor VIII levels in hemophilia A. Large inter-individual variation in the response to desmopressin is observed.
Janneke I. Loomans, Marieke J.H.A. Kruip, Manuel Carcao, Shannon Jackson, Alice S. van Velzen, Marjolein Peters, Elena Santagostino, Helen Platokouki, Erik Beckers, Jan Voorberg, Johanna G. van der Bom, Karin Fijnvandraat, for the RISE consortium   +12 more
doaj   +5 more sources

Desmopressin prescription safety in adult inpatients: a real-world tertiary centre experience [PDF]

Endocrine Connections
Omissions or delays in desmopressin can result in serious patient harm in patients with arginine vasopressin deficiency (AVP-D), formally known as cranial diabetes insipidus.
Muhammad Fahad Arshad, Sam Solanki, Luka Dancyger-Stevens, Madushani Karunanayaka, Ee-Wen Loh, Kyaw Naing Htoon, Mohanad Turki, Alia Munir   +7 more
doaj   +2 more sources

Hyponatremia due to preserved non-osmotic arginine vasopressin secretion in adipsic diabetes insipidus: a case report with review of literature [PDF]

Endocrine Journal
Adipsic diabetes insipidus (ADI) is characterized by central diabetes insipidus and an impaired thirst response to hyperosmolality, leading to hypernatremia.
Yasufumi Seki, Shun Sugawara, Saya Suzuki, Yulia Minakuchi, Kazuhisa Kusuki, Yuzo Mizuno   +5 more
doaj   +2 more sources

A comparison of the efficacy and tolerability of treating primary nocturnal enuresis with Solifenacin Plus Desmopressin, Tolterodine Plus Desmopressin, and Desmopressin alone: a randomized controlled clinical trial [PDF]

International Brazilian Journal of Urology, 2020
Introduction: Nocturnal enuresis (enuresis) is one of the most common developmental problems of childhood, which has often a familial basis, causes mental and psychological damage to the child and disrupts family solace.
Parvin Mousavi Ghanavati, Dinyar Khazaeli, Mohammadreza Amjadzadeh   +2 more
doaj   +1 more source

Predicting the Need for Desmopressin Treatment During Inpatient and After Discharge Following Endoscopic Sellar Surgery

Frontiers in Neurology, 2022
IntroductionPostoperative diabetes insipidus (DI) is a common complication following endoscopic sellar surgery. However, the requirement of desmopressin treatment for patients with DI are heterogenous.
Chia-En Wong, Wei-Hsin Wang, Wei-Hsin Wang, Ming-Ying Lan, Ming-Ying Lan, Po-Hsuan Lee, Chi-Chen Huang, Pei-Fang Su, Jung-Shun Lee, Jung-Shun Lee, Jung-Shun Lee   +10 more
doaj   +1 more source

Korean guideline of desmopressin for the treatment of nocturia in men [PDF]

Investigative and Clinical Urology, 2022
Purpose: Nocturia is the most bothersome of lower urinary tract symptoms in men. Desmopressin, a synthetic analog of the human hormone vasopressin, has been used for the treatment of nocturia.
Eu Chang Hwang , Hyun Jin Jung, Mi Ah Han, Myung Ha Kim, Seong Hyeon Yu, Hyun Cheol Jeong, Jun Seok Kim, Sung Hyun Paick, Jeong Kyun Yeo , Jae Hung Jung   +9 more
doaj   +1 more source

Effects of desmopressin acetate administration in healthy dogs receiving prednisolone

Journal of Veterinary Internal Medicine, 2021
Background Glucocorticoids are used for a variety of purposes in veterinary medicine but often are associated with clinically important adverse effects. Polyuria and polydipsia are the most frustrating adverse effects noted by owners.
Pamela Galati, Todd Archer, Robyn Jolly, Alyssa Sullivant, Robert Wills, Patty Lathan   +5 more
doaj   +1 more source

Desmopressin in combination with anticholinergic agents in the treatment of nocturnal enuresis: a systematic review and meta-analysis

Frontiers in Pediatrics, 2023
BackgroundThe desmopressin combined with anticholinergic agents for the treatment of nocturnal enuresis (NE) remains controversial. This meta-analysis assesses the efficacy and safety of desmopressin compared with desmopressin plus anticholinergic agents
Tong Cai, Yi Yao, Weigui Sun, Peipei Lei
doaj   +1 more source

Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing’s disease

Endocrine Connections, 2017
Recurrence of Cushing’s disease after successful transsphenoidal surgery occurs in some 30% of the patients and the response to desmopressin shortly after surgery has been proposed as a marker for disease recurrence.
Alberto Giacinto Ambrogio, Massimiliano Andrioli, Martina De Martin, Francesco Cavagnini, Francesca Pecori Giraldi   +4 more
doaj   +1 more source